.png)
Geographic Atrophy: Symptoms and Treatment for Advanced Dry Macular Degeneration
Dry age-related macular degeneration often progresses slowly, but in some people it reaches an advanced stage called geographic atrophy, or GA.
Geographic atrophy develops when areas of retinal cells and the supporting tissue beneath them gradually deteriorate. These areas expand over time, reducing the central vision needed for reading, recognizing faces, driving, and seeing fine detail.
For many years, treatment focused mainly on monitoring and helping patients make the most of their remaining vision.
That has changed.
Two medications are now approved in the United States specifically for geographic atrophy caused by age-related macular degeneration. These treatments do not restore retinal cells already lost, but they slow the progression of atrophy in selected patients.
Understanding what GA looks like, how it progresses, and what treatment is designed to accomplish helps patients make more informed decisions with their retina specialist.
1. What is geographic atrophy?
The macula is the central area of the retina responsible for detailed vision.
Geographic atrophy develops when patches of cells in and around the macula gradually die.
The affected areas include important structures such as:
photoreceptors, which detect light
retinal pigment epithelium, or RPE, which supports photoreceptors
surrounding retinal tissue
Doctors use the word geographic because the damaged areas often form clearly defined patches resembling shapes on a map when viewed during retinal imaging.
These patches usually enlarge gradually.
2. Geographic atrophy is an advanced form of dry AMD
Age-related macular degeneration has two major forms:
dry AMD
wet AMD
Most people with AMD begin with the dry form.
Dry AMD often starts with deposits called drusen and changes in the retinal pigment epithelium.
Many people remain in earlier stages for years.
Geographic atrophy represents an advanced stage of dry AMD in which areas of retinal tissue have been permanently lost.
Wet AMD follows a different process involving abnormal blood vessels growing beneath or within the retina.
A person can have geographic atrophy and later develop wet AMD as well, which is one reason continued monitoring remains important.
3. What does geographic atrophy vision look like?
GA mainly affects central and near-central vision.
Symptoms often begin gradually.
People describe:
difficulty reading small print
needing brighter light
reduced contrast
trouble recognizing faces
missing letters while reading
faded or dull colors
dark, blurry, or blank areas
difficulty adjusting between bright and dim environments
At first, the very center of vision sometimes remains relatively preserved while atrophy develops around it.
This produces an unusual experience where a person still reads individual letters but struggles with larger visual tasks.
4. Why reading often becomes difficult early
Reading requires more than seeing one letter sharply.
Your eyes need to see several letters and words around the point you are looking at.
Geographic atrophy often creates small missing areas close to central vision.
A patient might therefore notice:
letters disappearing
words becoming difficult to follow
losing their place while reading
needing to move their eyes or head to find a clearer area
Visual acuity on a standard eye chart sometimes remains better than the patient's real-world reading ability suggests.
This is why retina specialists consider symptoms and retinal imaging alongside the eye-chart measurement.
5. GA does not usually cause complete blindness
Geographic atrophy primarily damages central vision.
Peripheral vision often remains available.
This means most people with GA do not lose all sight.
However, central vision is important for many everyday activities, so advanced disease has a major effect on independence and quality of life.
Tasks affected include:
reading
driving
recognizing faces
cooking
managing medications
using phones and computers
seeing fine detail
Vision rehabilitation becomes increasingly important as these activities become harder.
6. How quickly does geographic atrophy progress?
Progression varies substantially between patients.
Some areas enlarge relatively slowly.
Others expand more quickly or develop in multiple locations.
The effect on vision also depends on where the atrophy is located.
An atrophic area away from the exact center of the macula might cause limited symptoms at first.
As it approaches or involves the fovea, detailed central vision becomes more affected.
Retinal imaging allows doctors to measure these changes over time.
7. Who is at higher risk?
Age is the strongest overall risk factor for AMD.
Other factors associated with increased AMD risk include:
family history
smoking
certain genetic factors
cardiovascular risk factors
previous AMD changes in either eye
Someone with intermediate or advanced AMD in one eye often needs careful monitoring of the other eye as well.
Having risk factors does not mean geographic atrophy will inevitably develop.
8. How is geographic atrophy diagnosed?
A comprehensive retinal examination usually includes dilation.
This lets the retina specialist examine the macula and surrounding retina directly.
Imaging provides much more detailed information.
OCT
Optical coherence tomography, or OCT, creates cross-sectional images of retinal layers.
With geographic atrophy, OCT shows thinning and loss of retinal structures.
It also helps doctors look for fluid suggesting wet AMD.
Fundus autofluorescence
Fundus autofluorescence imaging highlights patterns related to the health of the retinal pigment epithelium.
It is useful for showing the boundaries of geographic atrophy and monitoring how the damaged area enlarges.
Retinal photography
Photographs provide a clear record of changes in the macula between appointments.
Different imaging methods often complement each other.
9. Why regular monitoring still matters
Geographic atrophy is usually gradual rather than an emergency.
Regular appointments remain important because the retina changes over time.
Monitoring helps your retina specialist evaluate:
how quickly atrophy is enlarging
whether the fovea is involved
whether the other eye is changing
whether wet AMD has developed
whether treatment is appropriate
how vision is affecting daily activities
A sudden change should not automatically be blamed on geographic atrophy.
Wet AMD and other retinal problems sometimes appear alongside existing dry AMD.
10. Are there treatments for geographic atrophy now?
Yes.
In the United States, two complement-inhibitor medications are approved specifically for geographic atrophy secondary to AMD:
pegcetacoplan, marketed as Syfovre
avacincaptad pegol, marketed as Izervay
Both are given as injections into the eye.
These medications target parts of the complement system, a component of the immune system involved in inflammation and AMD biology.
Treatment aims to slow enlargement of geographic atrophy.
It does not regenerate retinal tissue which has already been lost.
11. What should patients expect from treatment?
The goal is different from the goal of anti-VEGF injections used for wet AMD.
With wet AMD, treatment sometimes produces noticeable improvement in vision by reducing abnormal vessel leakage.
With geographic atrophy, complement-inhibitor treatment is intended to slow future progression.
A patient might not feel a dramatic difference after each injection.
The potential benefit accumulates by slowing the rate at which the atrophic area expands over time.
This makes treatment a long-term decision balancing:
current vision
location of atrophy
rate of progression
treatment burden
risks of injections
expected benefit for that individual
Not everyone with GA makes the same treatment choice.
12. What are Syfovre and Izervay?
Syfovre contains pegcetacoplan and targets complement protein C3.
Izervay contains avacincaptad pegol and targets complement protein C5.
Both interfere with different points in the complement pathway.
The U.S. Food and Drug Administration approved both medications for geographic atrophy secondary to AMD.
The injection schedule differs between treatments, so the retina specialist discusses the appropriate regimen with each patient.
13. Do these injections restore lost vision?
No.
This is one of the most important expectations to understand.
Complement-inhibitor treatments slow progression rather than restore retinal cells already destroyed by geographic atrophy.
If an area of central retina has already been lost, current medications do not rebuild it.
This is why treatment discussions often focus on preserving retinal tissue which remains healthy for as long as possible.
14. What are the risks of treatment?
Intravitreal injections have potential risks.
These include uncommon but serious complications such as:
infection inside the eye
retinal detachment
inflammation
Complement-inhibitor treatment also increases the chance of developing neovascular, or wet, AMD in some patients.
Your retina specialist weighs these risks against the expected benefit of slowing geographic atrophy.
The decision depends on the individual rather than simply whether GA is present.
15. AREDS2 vitamins and geographic atrophy
Patients with AMD often ask about AREDS2 supplements.
AREDS2 vitamins are recommended for certain people with intermediate AMD or particular patterns of advanced AMD because they reduce the risk of progression to late AMD in appropriate patients.
They are not a treatment that reverses geographic atrophy, and they have not been shown to restore areas of retinal tissue already lost.
Whether AREDS2 is appropriate depends on the stage of AMD in each eye.
Your eye doctor should determine whether the formulation fits your individual situation.
Our upcoming AREDS2 blog will explain this in more detail.
16. What happens if geographic atrophy affects daily life?
Treatment is only one part of managing advanced dry AMD.
Low-vision rehabilitation helps patients use remaining vision more effectively.
Useful tools include:
stronger reading magnification
electronic magnifiers
larger phone and computer text
high-contrast displays
brighter task lighting
text-to-speech software
audiobooks
voice assistants
Vision rehabilitation specialists also teach techniques for using areas of healthier retina when central vision becomes limited.
These services support independence rather than simply measuring how much vision has been lost.
17. Lifestyle still matters
Lifestyle changes do not reverse geographic atrophy.
They still support overall eye and cardiovascular health.
Important steps include:
avoiding smoking
maintaining regular physical activity
managing blood pressure
managing cholesterol
eating a balanced diet rich in vegetables and other nutrient-dense foods
attending recommended eye examinations
Smoking is one of the strongest modifiable risk factors for AMD.
18. Watch for signs of wet AMD
Someone with geographic atrophy may also develop wet AMD.
Contact your retina specialist promptly if you notice:
sudden new distortion
straight lines becoming much more wavy
a new dark central spot
sudden worsening of central blur
a rapid change in one eye
These changes sometimes indicate new fluid or bleeding from abnormal blood vessels.
OCT imaging helps distinguish progression of atrophy from conversion to wet AMD.
19. Using an Amsler grid at home
Some patients with AMD are advised to monitor central vision using an Amsler grid.
The grid contains straight horizontal and vertical lines with a central point.
With one eye covered, look at the central point.
Contact your eye doctor if you notice a new area where:
lines appear wavy
sections are missing
a dark spot appears
distortion suddenly increases
The Amsler grid does not replace scheduled retinal examinations.
It provides one additional way to notice changes between visits.
When should you see a retina specialist?
Schedule a retinal evaluation if:
you have been diagnosed with intermediate or advanced dry AMD
reading has become more difficult
you notice missing central areas
faces are becoming harder to recognize
an eye doctor has mentioned geographic atrophy
you want to discuss whether GA treatment is appropriate
Treatment decisions are most useful when based on detailed retinal imaging and the location and progression of the atrophy.
Seek faster care for sudden changes
Geographic atrophy generally changes gradually.
Seek prompt eye care if you develop:
sudden major central blur
new severe distortion
a sudden dark central spot
flashes and new floaters
a curtain or shadow
sudden vision loss
A rapid change suggests another retinal process rather than ordinary GA progression.
What this means for your eyes
Geographic atrophy is an advanced form of dry age-related macular degeneration in which areas of retinal cells gradually disappear.
It primarily affects central vision and often makes reading, recognizing faces, and seeing fine detail increasingly difficult.
Modern imaging helps retina specialists measure progression with considerable precision.
The introduction of complement-inhibitor injections has also changed the treatment landscape. For the first time, medications are available in the United States which slow the progression of geographic atrophy in selected patients.
They do not restore retinal tissue already lost, so realistic expectations and careful patient selection remain important.
Book with South Bay Retina
If you have dry macular degeneration, geographic atrophy, new central vision changes, or questions about newer GA treatments, schedule a retinal evaluation with South Bay Retina.
Detailed retinal imaging helps determine the stage and location of AMD, track progression, and guide a discussion about whether treatment or continued monitoring is appropriate.
Comments